Metro Healthcare Indonesia Tbk PT CARE.JK · IDR

Health Care · IDX · 🇮🇩 Indonesia

Compare

360

-3.74%

Close of 9 Nov 2026, in IDR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in IDR, from our data supplier.

FY2025

Revenue

IDR 439.75bn

FY2016FY2025

Net income

IDR 4.95bn

FY2016FY2025

Free cash flow

−IDR 164.87bn

FY2016FY2025

Shareholders' equity

IDR 3.02trn

FY2016FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	IDR 439.75bn	IDR 319.02bn	IDR 242.68bn	IDR 260.43bn	IDR 290.93bn	IDR 216.30bn	IDR 154.08bn	IDR 87.21bn	IDR 31.20bn	—
Gross profit	IDR 215.16bn	IDR 104.59bn	IDR 89.65bn	IDR 96.23bn	IDR 145.93bn	IDR 102.89bn	IDR 75.66bn	IDR 37.66bn	IDR 14.86bn	—
Operating income	IDR 72.87bn	−IDR 4.69bn	−IDR 36.14bn	−IDR 34.95bn	IDR 16.56bn	−IDR 15.52bn	IDR 8.67bn	−IDR 3.48bn	IDR 847.4m	−IDR 175.0m
Net income	IDR 4.95bn	−IDR 80.31bn	−IDR 110.92bn	−IDR 93.54bn	IDR 6.10bn	IDR 14.31bn	−IDR 24.21bn	−IDR 27.49bn	−IDR 11.52bn	IDR 10.42bn
Diluted earnings per share	0.15	-2.42	-3.34	-2.81	0.18	0.43	-0.91	-0.83	-0.35	0.31

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Total assets	IDR 4.18trn	IDR 4.02trn	IDR 4.14trn	IDR 4.23trn	IDR 4.21trn	IDR 3.45trn	IDR 2.45trn	IDR 552.01bn	IDR 328.02bn	IDR 221.47bn
Cash and short-term investments	IDR 470.74bn	IDR 492.07bn	IDR 754.76bn	IDR 853.21bn	IDR 1.19trn	IDR 725.48bn	IDR 226.95bn	IDR 7.94bn	IDR 11.30bn	IDR 2.81bn
Total liabilities	IDR 1.15trn	IDR 1.00trn	IDR 1.04trn	IDR 1.03trn	IDR 912.94bn	IDR 154.91bn	IDR 175.33bn	IDR 579.15bn	IDR 316.69bn	IDR 210.85bn
Debt	IDR 1.08trn	IDR 944.47bn	IDR 954.51bn	IDR 308.27bn	IDR 195.84bn	IDR 116.16bn	IDR 132.72bn	IDR 141.88bn	IDR 92.18bn	IDR 70.80bn
Shareholders' equity	IDR 3.02trn	IDR 3.02trn	IDR 3.10trn	IDR 3.21trn	IDR 3.30trn	IDR 3.29trn	IDR 2.27trn	−IDR 28.24bn	−IDR 1.01bn	IDR 10.67bn
Shares outstanding	33,250m	33,250m	33,250m	33,250m	33,250m	33,250m	26,583m	33,250m	33,250m	33,250m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash from operations	IDR 45.89bn	−IDR 113.01bn	−IDR 83.03bn	−IDR 93.60bn	IDR 47.13bn	IDR 50.30bn	−IDR 22.98bn	−IDR 29.03bn	−IDR 17.10bn	−IDR 1.1m
Capital spending	−IDR 210.76bn	−IDR 226.93bn	−IDR 12.56bn	−IDR 290.45bn	−IDR 310.40bn	−IDR 522.27bn	−IDR 363.31bn	−IDR 215.10bn	−IDR 48.81bn	−IDR 4.33bn
Free cash flow	−IDR 164.87bn	−IDR 339.94bn	−IDR 95.60bn	−IDR 384.06bn	−IDR 263.28bn	−IDR 471.97bn	−IDR 386.29bn	−IDR 244.13bn	−IDR 65.91bn	−IDR 4.33bn

Latest quarters

By quarter end

	Jun 2026	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024
Revenue	IDR 91.20bn	IDR 120.22bn	IDR 204.49bn	IDR 77.22bn	IDR 80.99bn	IDR 77.04bn	IDR 80.64bn	IDR 72.93bn
Gross profit	IDR 54.25bn	IDR 64.85bn	IDR 93.10bn	IDR 33.86bn	IDR 62.32bn	IDR 25.88bn	IDR 30.55bn	IDR 21.71bn
Operating income	IDR 27.36bn	IDR 23.66bn	IDR 37.27bn	IDR 5.99bn	IDR 41.55bn	−IDR 13.63bn	IDR 9.41bn	−IDR 4.51bn
Net income	IDR 2.17bn	IDR 140.7m	IDR 2.64bn	IDR 1.05bn	IDR 30.29bn	−IDR 29.02bn	−IDR 10.91bn	−IDR 24.03bn
Diluted earnings per share	0.07	0.00	0.08	0.03	0.91	-0.87	-0.33	-0.72
Cash from operations	−IDR 6.29bn	IDR 15.19bn	IDR 14.35bn	IDR 16.50bn	IDR 38.24bn	−IDR 23.20bn	−IDR 34.66bn	−IDR 14.80bn
Capital spending	−IDR 4.08bn	−IDR 2.19bn	−IDR 204.51bn	−IDR 1.77bn	−IDR 31.0m	−IDR 4.51bn	−IDR 187.35bn	−IDR 34.44bn
Free cash flow	−IDR 10.37bn	IDR 13.00bn	−IDR 190.16bn	IDR 14.74bn	IDR 38.20bn	−IDR 27.72bn	−IDR 222.01bn	−IDR 49.24bn
Total assets	IDR 4.16trn	IDR 4.17trn	IDR 4.18trn	IDR 4.19trn	IDR 3.90trn	IDR 3.98trn	IDR 4.02trn	IDR 4.01trn
Cash and short-term investments	IDR 470.28bn	IDR 472.27bn	IDR 470.74bn	IDR 757.56bn	IDR 453.86bn	IDR 449.98bn	IDR 492.07bn	IDR 513.13bn
Debt	IDR 1.06trn	IDR 1.07trn	IDR 1.08trn	IDR 1.10trn	IDR 818.11bn	IDR 935.22bn	IDR 944.47bn	IDR 923.40bn
Shareholders' equity	IDR 3.02trn	IDR 3.02trn	IDR 3.02trn	IDR 3.02trn	IDR 3.02trn	IDR 2.99trn	IDR 3.02trn	IDR 3.03trn

Financial ratios

Data as of 26 Aug 2026

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Gross margin	48.9%	32.8%	36.9%	37.0%	50.2%	47.6%
Operating margin	16.6%	-1.5%	-14.9%	-13.4%	5.7%	-7.2%
Net margin	1.1%	-25.2%	-45.7%	-35.9%	2.1%	6.6%
Return on equity	0.2%	-2.7%	-3.6%	-2.9%	0.2%	0.4%
Return on assets	0.1%	-2.0%	-2.7%	-2.2%	0.1%	0.4%
Free cash flow yield	1.8%	0.8%	-0.5%	1.3%	2.4%	3.9%
Revenue growth	37.8%	31.5%	-6.8%	-10.5%	34.5%	40.4%
Earnings growth	-106.2%	-27.6%	18.6%	-1633.7%	-57.4%	-159.1%
Current ratio	0.84x	0.62x	0.88x	4.14x	16.15x	16.14x
Debt to equity	0.36x	0.31x	0.31x	0.10x	0.06x	0.04x
Equity ratio	72.4%	75.0%	74.8%	75.7%	78.3%	95.5%
Interest coverage	0.91x	-0.06x	-0.47x	-0.39x	0.64x	-1.37x
Buybacks as a share of market value	0.0%	0.0%	0.0%	0.0%	-0.0%	-25.1%

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	19.1%	15.2%	—
Net income	—	-19.1%	—

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	42.1%	40.1%	42.6%	—

Valuation history

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Price to earnings	—	-78.3	-48.0	-169.2	—	—
Price to sales	51.4	19.7	21.9	60.8	58.9	49.5

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Metro Healthcare Indonesia Tbk PT CARE.JK · IDR

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Financial ratios

Growth per year

Average margins

Valuation history

Sources and methodology